Diagnostic mammogram readings vary extensively by radiologist

December 11, 2007

Radiologists' interpretation of diagnostic mammograms varies widely and could not be explained by differences in patient populations, according to a study published online December 11 in the Journal of the National Cancer Institute. This variation could affect clinical decisions in large numbers of women.

Several studies have demonstrated extensive variability in radiologists' interpretation of screening mammograms, but less is known about their performance with diagnostic mammograms. Diagnostic mammograms are used to explore suspicious findings from either physical exams or screening mammograms.

Diana Miglioretti, Ph.D., of the Group Health Center for Health Studies in Seattle and colleagues evaluated whether radiologists' experience or other characteristics influenced their interpretation of diagnostic mammograms. The researchers examined the performance of 123 radiologists who interpreted nearly 36,000 diagnostic mammograms at 72 facilities that contribute data to the Breast Cancer Surveillance Consortium. They evaluated the extent to which radiologists' characteristics, such as experience and affiliation, influenced the accuracy of their mammography reading.

About three quarters of the radiologists had been interpreting mammograms for at least 10 years. Most radiologists (87 percent) spent less than 40 percent of their time interpreting mammograms, and about a quarter of them interpreted 100 mammograms or less in a year. The median age of the radiologists was 49 years and three quarters of them were male.

The researchers found considerable variation in the radiologists' performance, and it was not explained by patient characteristics. About 80 percent of breast cancers were correctly diagnosed, but more than 4 percent of women without cancer were given a tentative cancer diagnosis based on their mammogram. Radiologists who were affiliated with an academic institution were more likely to correctly diagnose a cancer and were less likely to diagnose a cancer that didn't exist. But only seven radiologists with an academic affiliation were included in the study, so that result must be interpreted with caution. Radiologists with more experience were likely to have a higher threshold for recommending a biopsy, while those who spent more time interpreting mammograms were more likely to have a lower threshold for biopsy recommendations.

"Because the rate of breast cancer is 10-fold higher among diagnostic mammograms than among screening mammograms and the majority of women with breast cancer have a physical sign or symptom at the time of diagnosis, this variability in interpretive performance is concerning and likely affects many women both with and without breast cancer," the authors write. "To realistically improve mammography interpretation for women across the United States, we need to identify ways to improve accuracy and reduce variability among all radiologists who interpret mammography."
Contact: Joan Declaire, media office, Group Health Center for Health Studies, declaire.j@ghc.org, (206) 287-2653

Citations: Miglioretti DL, Smith-Bindman R, Abraham L, Brenner RJ, Carney PA, et al. Radiologist Characteristics Associated With Interpretive Performance of Diagnostic Mammography. J Natl Cancer Inst 2007; 99:1854-1863

Note to Reporters:

We have started up an e-mail list to alert reporters when papers are available on the EurekAlert site. If you would be interested on being on this list, please let us know at jncimedia@oxfordjournals.org. The content will continue to be available through EurekAlert's e-mail system and our EurekAlert page.

The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage. Visit the Journal online at http://jnci.oxfordjournals.org/.

Journal of the National Cancer Institute

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.